1、加样:分别设空白孔(空白对照孔不加样品及酶标试剂,其余各步操作相同)、标准孔、待测样品孔。在酶标包被板上标准品准确加样50µl,待测样品孔中先加样品稀释液40µl,然后再加待测样品10µl(样品稀释度为5倍)。加样将样品加于酶标板孔底部,尽量不触及孔壁,轻轻晃动混匀。
6、显色:每孔先加入显色剂A50µl,再加入显色剂B50µl,轻轻震荡混匀,37℃避光显色10 分钟.
名称:甲基紫 [8004-87-3]
英文:methyl violet分子式:C25H30CLN3分子量:407.99
别名:甲基青莲,碱性紫1,苯胺紫
名称:甲基紫 [8004-87-3]
英文:methyl violet分子式:C25H30CLN3分子量:407.99
别名:甲基青莲,碱性紫1,苯胺紫
名称:结晶紫 [548-62-9]
英文:Crystal violet分子式:C25H30N3CL分子量:407.98
别名:甲基青莲,甲紫,甲基紫,龙胆紫,碱性紫3
名称:结晶紫 [548-62-9]
英文:Crystal violet分子式:C25H30N3CL分子量:407.98
别名:甲基青莲,甲紫,甲基紫,龙胆紫,碱性紫3
名称:结晶紫 [548-62-9]
英文:Crystal violet分子式:C25H30N3CL分子量:407.98
别名:甲基青莲,甲紫,甲基紫,龙胆紫,碱性紫3
名称:结晶紫 [548-62-9]
英文:Crystal violet分子式:C25H30N3CL分子量:407.98
别名:甲基青莲,甲紫,甲基紫,龙胆紫,碱性紫3
名称:结晶紫 [548-62-9]
英文:Crystal violet分子式:C25H30N3CL分子量:407.98
别名:甲基青莲,甲紫,甲基紫,龙胆紫,碱性紫3
名称:结晶紫 [548-62-9]
英文:Crystal violet分子式:C25H30N3CL分子量:407.98
别名:甲基青莲,甲紫,甲基紫,龙胆紫,碱性紫3
名称:结晶紫 [548-62-9]
英文:Crystal violet分子式:C25H30N3CL分子量:407.98
别名:甲基青莲,甲紫,甲基紫,龙胆紫,碱性紫3
名称:结晶紫 [548-62-9]
英文:Crystal violet分子式:C25H30N3CL分子量:407.98
别名:甲基青莲,甲紫,甲基紫,龙胆紫,碱性紫3
名称:溴甲酚紫 [115-40-2]
英文:Bromocresol purple分子式:C21H16BR2O5S分子量:540.24 562.20
别名:二溴邻甲酚磺酜酞
名称:溴甲酚紫 [115-40-2]
英文:Bromocresol purple分子式:C21H16BR2O5S分子量:540.24 562.20
别名:二溴邻甲酚磺酜酞
名称:溴甲酚紫 [115-40-2]
英文:Bromocresol purple分子式:C21H16BR2O5S分子量:540.24 562.20
别名:二溴邻甲酚磺酜酞
名称:专利蓝VF [129-17-9]AP-18 (10 mg)4-(4-chlorophenyl)-3-methyl-3-buten-2-one, oxime; AP-18
AP-18 (25 mg)4-(4-chlorophenyl)-3-methyl-3-buten-2-one, oxime; AP-18
AP-18 (5 mg)4-(4-chlorophenyl)-3-methyl-3-buten-2-one, oxime; AP-18
AP-18 (50 mg)4-(4-chlorophenyl)-3-methyl-3-buten-2-one, oxime; AP-18
(S)-Mephenytoin (1 mg)(5S)-5-ethyl-3-methyl-5-phenyl-2,4-imidazolidinedione; (S)-5-Ethyl-3-methyl-5-phenylhydantoin; (S)-Mephenytoin
(S)-Mephenytoin (10 mg)(5S)-5-ethyl-3-methyl-5-phenyl-2,4-imidazolidinedione; (S)-5-Ethyl-3-methyl-5-phenylhydantoin; (S)-Mephenytoin
(S)-Mephenytoin (25 mg)(5S)-5-ethyl-3-methyl-5-phenyl-2,4-imidazolidinedione; (S)-5-Ethyl-3-methyl-5-phenylhydantoin; (S)-Mephenytoin
(S)-Mephenytoin (5 mg)(5S)-5-ethyl-3-methyl-5-phenyl-2,4-imidazolidinedione; (S)-5-Ethyl-3-methyl-5-phenylhydantoin; (S)-Mephenytoin
EAM2201 (25 mg)(4-ethyl-1-naphthalenyl)[1-(5-fluoropentyl)-1H-indol-3-yl]-methanone; JWH 210 N-(5-fluoropentyl) analog; EAM2201
EAM2201 (50 mg)(4-ethyl-1-naphthalenyl)[1-(5-fluoropentyl)-1H-indol-3-yl]-methanone; JWH 210 N-(5-fluoropentyl) analog; EAM2201
25D-NBOMe (hydrochloride) (50 mg)2-(2,5-dimethoxy-4-methylphenyl)-N-(2-methoxybenzyl)ethanamine, monohydrochloride; 2C-D-NBOMe; 25D-NBOMe (hydrochloride)
25I-NBMD (hydrochloride) (1 mg)N-(benzo[d][1,3]dioxol-4-ylmethyl)-2-(4-iodo-2,5-dimethoxyphenyl)ethanamine, monohydrochloride; Cimbi-29; 25I-NBMD (hydrochloride)
人DNA拓扑异构酶1(TOP1)自身抗体(ELisa)酶联免疫试剂盒25I-NBMD (hydrochloride) (10 mg)N-(benzo[d][1,3]dioxol-4-ylmethyl)-2-(4-iodo-2,5-dimethoxyphenyl)ethanamine, monohydrochloride; Cimbi-29; 25I-NBMD (hydrochloride)
25I-NBMD (hydrochloride) (5 mg)N-(benzo[d][1,3]dioxol-4-ylmethyl)-2-(4-iodo-2,5-dimethoxyphenyl)ethanamine, monohydrochloride; Cimbi-29; 25I-NBMD (hydrochloride)
AMD 3465 (hydrobromide) (10 mg)N-[[4-(1,4,8,11-tetraazacyclotetradec-1-ylmethyl)phenyl]methyl]-2-pyridinemethanamine, hexahydrobromide; AMD 3465 (hydrobromide)
AMD 3465 (hydrobromide) (25 mg)N-[[4-(1,4,8,11-tetraazacyclotetradec-1-ylmethyl)phenyl]methyl]-2-pyridinemethanamine, hexahydrobromide; AMD 3465 (hydrobromide)
AMD 3465 (hydrobromide) (5 mg)N-[[4-(1,4,8,11-tetraazacyclotetradec-1-ylmethyl)phenyl]methyl]-2-pyridinemethanamine, hexahydrobromide; AMD 3465 (hydrobromide)
英文:Patent Blue VF分子式:C27H31N2NAO6S2分子量:566.66